Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ahmed H. Albariqi"'
Autor:
Fazli Khuda, Irum Zahir, Atif Ali Khan Khalil, Sajid Ali, Naveed Ullah, Ahmed H. Albariqi, Mi-Jeong Ahn, Muhammad Shafique, Sultan Mehtap Büyüker, Saud Almawash
Publikováno v:
ACS Omega, Vol 8, Iss 37, Pp 33955-33965 (2023)
Externí odkaz:
https://doaj.org/article/0286060876d649f3ab49ebabd2c3fc88
Autor:
Ahmed H. Albariqi, Yuncheng Wang, Rachel Yoon Kyung Chang, Diana H. Quan, Xiaonan Wang, Stefanie Kalfas, John Drago, Warwick J. Britton, Hak-Kim Chan
Publikováno v:
International journal of pharmaceutics. 619
Pharmacokinetic limitations associated with oral ivermectin may limit its success as a potential COVID-19 treatment based on in vitro experiments which demonstrate antiviral efficacy against SARS-CoV-2 at high concentrations. Targeted delivery to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d825d64aa4110865a726ad4dca5146
https://pubmed.ncbi.nlm.nih.gov/35314278
https://pubmed.ncbi.nlm.nih.gov/35314278
Autor:
Ahmed H. Albariqi, Wei-Ren Ke, Dipesh Khanal, Stefanie Kalfas, Patricia Tang, Warwick J Britton, John Drago, Hak-Kim Chan
biBackground:/i/bIvermectin has received worldwide attention as a potential COVID-19 treatment after showing antiviral activity against SARS-CoV-2iin vitro./iHowever, the pharmacokinetic limitations associated with oral administration have been postu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a7eb6fcd04bc0758dadda6301ac929
https://hdl.handle.net/2123/28304
https://hdl.handle.net/2123/28304
